| Janssen-Cilag AG - Risperdal Consta 25 mg, Suspension zur i.m. Applikation | | 56092 | | 01 | | Risperdal Consta 25 mg | | Suspension zur i.m. Applikation | | N05AX08 | | Risperidon | | 26.06.2002 | | |
| | Composition | | Praeparatio sicca: risperidonum 25 mg, poly(lactidum-co-glycolidum).
Solvens: carmellosum natricum, polysorbatum 20, dinatrii phosphas dihydricus, acidum citricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml, pro vase, in suspensione recenter reconstituta corresp. natrium 9.872 mg. | | Packungsbestandteile | | Injektionssuspension | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Risperidon | 25 mg | Praeparatio sicca |
| | BAG: Principe actif | Concentr. |
|---|
| Risperidon | 25 mg |
| | | | Agents auxilliaires |
|---|
| Poly(Lactidum-Co-Glycolidum) |
| |
| Solvens | | | Injektionssuspension | | | | | | | | | BAG: Principe actif | Concentr. |
|---|
| Risperidon | 25 mg |
| | | | Agents auxilliaires |
|---|
| Citratsäure | | Carmellose Natrium | | Dinatrium Phosphat Dihydrat | | Natrium Chlorid | | Natrium Hydroxid | | Polysorbatum 20 |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | Set(s) | 98.36 | 121.80 | B | LS | Oui |
|
|
